Compounds > meclofenamic acid
Page last updated: 2024-10-30

meclofenamic acid and Astrocytoma, Grade IV

meclofenamic acid has been researched along with Astrocytoma, Grade IV in 3 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Glioblastoma is the most frequent and malignant primary brain tumor."7.11Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. ( Becker, A; Burger, MC; Clusmann, H; Delev, D; Giordano, FA; Glas, M; Goldbrunner, R; Grauer, O; Güresir, E; Hau, P; Heiland, DH; Herrlinger, U; Krex, D; Nemeth, R; Potthoff, AL; Radbruch, A; Sabel, M; Schaub, C; Schilling, J; Schlegel, U; Schmid, M; Schneider, M; Schnell, O; Schuss, P; Seidel, C; Steinbach, JP; Tabatabai, G; Thon, N; Vatter, H; Weller, J; Winkler, F; Zeyen, T, 2022)
"Glioblastoma is the most frequent and malignant primary brain tumor."3.11Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. ( Becker, A; Burger, MC; Clusmann, H; Delev, D; Giordano, FA; Glas, M; Goldbrunner, R; Grauer, O; Güresir, E; Hau, P; Heiland, DH; Herrlinger, U; Krex, D; Nemeth, R; Potthoff, AL; Radbruch, A; Sabel, M; Schaub, C; Schilling, J; Schlegel, U; Schmid, M; Schneider, M; Schnell, O; Schuss, P; Seidel, C; Steinbach, JP; Tabatabai, G; Thon, N; Vatter, H; Weller, J; Winkler, F; Zeyen, T, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Zeyen, T1
Potthoff, AL2
Nemeth, R1
Heiland, DH2
Burger, MC1
Steinbach, JP1
Hau, P1
Tabatabai, G1
Glas, M1
Schlegel, U1
Grauer, O1
Krex, D1
Schnell, O2
Goldbrunner, R1
Sabel, M1
Thon, N1
Delev, D1
Clusmann, H1
Seidel, C1
Güresir, E2
Schmid, M1
Schuss, P2
Giordano, FA1
Radbruch, A1
Becker, A1
Weller, J1
Schaub, C1
Vatter, H2
Schilling, J1
Winkler, F1
Herrlinger, U2
Schneider, M2
Vollmer, L1
Ravi, VM1
Evert, BO1
Rahman, MA1
Sarowar, S1
Kueckelhaus, J1
Will, P1
Zurhorst, D1
Joseph, K1
Maier, JP1
Neidert, N1
d'Errico, P1
Meyer-Luehmann, M1
Hofmann, UG1
Dolf, A1
Salomoni, P1
Enger, PØ1
Chekenya, M1
Pietsch, T1
Westhoff, MA1
Beck, J1
Waha, A1
Cui, Q1
Shi, H1
Ye, P1
Li, L1
Qu, Q1
Sun, G2
Lu, Z1
Huang, Y1
Yang, CG1
Riggs, AD1
He, C1
Shi, Y1

Trials

1 trial available for meclofenamic acid and Astrocytoma, Grade IV

ArticleYear
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
    Trials, 2022, Jan-19, Volume: 23, Issue:1

    Topics: Antineoplastic Agents, Alkylating; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Hu

2022

Other Studies

2 other studies available for meclofenamic acid and Astrocytoma, Grade IV

ArticleYear
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma.
    Neuro-oncology, 2021, 11-02, Volume: 23, Issue:11

    Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; In Vitro Techniques; Me

2021
m
    Cell reports, 2017, 03-14, Volume: 18, Issue:11

    Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Base Sequence; Brain Neoplasms; C

2017